As Omic Technologies Head Toward Global View, Multi-Platform Firms Align for Change | GenomeWeb

The quest to understand and interpret the human genome has fueled the development of a unique set of companies within the molecular biology tools sector.

These companies provide multiple technologies across the sequencing, genomics, proteomics, and metabolomics markets. All of these companies are wrestling with the financial demands of growing their businesses in a market that is moving as fast as 21st century science and innovation will allow.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.